HCA Healthcare, Inc. $HCA Shares Bought by Gobi Capital LLC

Key Points

• Gobi Capital LLC increased its stake in HCA Healthcare by 9.8%, owning approximately $140.15 million worth of its stock, making it the fifth largest position in their portfolio.
• HCA Healthcare reported earnings of $6.84 per share for the last quarter, surpassing analysts' expectations of $6.20, and its revenue rose 6.4% year-over-year to $18.61 billion.
• The company recently announced a quarterly dividend of $0.72, resulting in an annualized yield of 0.7%, with a payout ratio of 12.11%.

Gobi Capital LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 405,587 shares of the company's stock after buying an additional 36,100 shares during the quarter. HCA Healthcare makes up approximately 8.0% of Gobi Capital LLC's investment portfolio, making the stock its 5th largest position. Gobi Capital LLC owned about 0.17% of HCA Healthcare worth $140,151,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently added to or reduced their stakes in HCA. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare in the 1st quarter valued at $27,000. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $28,000. Bartlett & CO. Wealth Management LLC lifted its stake in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. Finally, ORG Partners LLC lifted its stake in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on HCA shares. Truist Financial upped their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Royal Bank Of Canada decreased their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Robert W. Baird increased their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Cantor Fitzgerald reissued an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday, August 26th. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Stock Down 0.8%

HCA stock traded down $3.17 during mid-day trading on Monday, reaching $404.11. The company had a trading volume of 996,401 shares, compared to its average volume of 1,110,551. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The company has a market capitalization of $94.56 billion, a price-to-earnings ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. The firm has a fifty day simple moving average of $377.43 and a 200 day simple moving average of $357.80. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the company earned $5.50 EPS. HCA Healthcare's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.